Kinoteck Therapeutics Co. Ltd. have prepared and tested new ribosomal protein S6 kinase alpha-3 (RSK-2; MAPKAPK-1b) inhibitors potentially useful for the treatment of cancer.
Research from WashU Medicine found a possible new treatment strategy for certain types of blood cancers. The bone marrow of a mouse with a myeloproliferative neoplasm (left) shows fibrosis, or scar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results